<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1946356" created="12/03/2006" creator="Hitomi MASUDA"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1946356</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="negative_regulation" sem="Other">Negative regulation</term> of <term id="T2" lex="human_immunodeficiency_virus_type_1_expression" sem="Other"><term id="T3" lex="human_immunodeficiency_virus_type_1" sem="Virus">human immunodeficiency virus type 1</term> expression</term> in monocytes: role of the <term id="T4" lex="65-kDa" sem="Protein_molecule">65-kDa</term> plus <term id="T5" lex="50-kDa_NF-kappa_B_dimer" sem="Protein_complex">50-kDa <term id="T6" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> dimer</term>.</sentence>
<event id="E1">
<type class="Gene_expression"/>
<theme idref="T3"/>
<clue>Negative regulation of human immunodeficiency virus type 1 <clueType>expression</clueType> <clueLoc>in monocytes</clueLoc>: role of the 65-kDa plus 50-kDa NF-kappa B dimer.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<clue><clueType>Negative regulation</clueType> <linkTheme>of</linkTheme> human immunodeficiency virus type 1 expression in monocytes: role of the 65-kDa plus 50-kDa NF-kappa B dimer.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Although <term id="A2" sem="Cell_natural">monocytic cells</term> can provide a reservoir for viral production in vivo, their regulation of <term id="T7" lex="human_immunodeficiency_virus_type_1_(HIV-1)_transcription" sem="Other"><term id="T8" lex="human_immunodeficiency_virus_type_1" sem="Virus">human immunodeficiency virus type 1</term> (<term id="T9" lex="HIV-1" sem="Virus">HIV-1</term>) transcription</term> can be either latent, restricted, or productive.</sentence>
<event KT="Other" id="E3">
<type class="Transcription"/>
<theme idref="T9"/>
<clue>Although monocytic cells can provide a reservoir for viral production in vivo, their regulation of human immunodeficiency virus type 1 (HIV-1) <clueType>transcription</clueType> can be either latent, restricted, or productive.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Regulation"/>
<theme idref="E3"/>
<cause idref="A2"/>
<clue>Although monocytic cells can provide a reservoir for viral production in vivo, <corefCause>their</corefCause> <clueType>regulation</clueType> <linkTheme>of</linkTheme> human immunodeficiency virus type 1 (HIV-1) transcription can be either latent, restricted, or productive.</clue>
</event>
<event KT="Other" id="E100">
<type class="Viral_life_cycle"/>
<theme idref="T9"/>
<clue>Although monocytic cells can provide a reservoir for <clueType>viral production</clueType> in vivo, their regulation of human immunodeficiency virus type 1 (HIV-1) transcription can be either latent, restricted, or productive.</clue>
</event>
<sentence id="S3">These differences in gene expression have not been molecularly defined.</sentence>
<sentence id="S4">In <term id="T10" lex="THP-1_cell" sem="Cell_cultured">THP-1 cells</term> with restricted <term id="T11" lex="HIV_expression" sem="Other"><term id="A3" sem="Virus">HIV</term> expression</term>, there is an absence of <term id="T12" lex="DNA-protein_binding_complex" sem="Protein_complex"><term id="A11" sem="DNA_domain_or_region">DNA</term>-<term id="A12" sem="Protein_molecule">protein</term> binding complex</term> formation with the <term id="T13" lex="HIV-1_promoter-enhancer" sem="DNA_domain_or_region"><term id="T14" lex="HIV-1" sem="Virus">HIV-1</term> promoter-enhancer</term> associated with markedly less <term id="T15" lex="viral_RNA_production" sem="Other"><term id="T16" lex="viral_RNA" sem="RNA_family_or_group">viral RNA</term> production</term>.</sentence>
<event KT="Other" id="E101">
<type class="Gene_expression"/>
<theme idref="A3"/>
<clue>In THP-1 cells with restricted HIV <clueType>expression</clueType>, there is an absence of DNA-protein binding complex formation with the HIV-1 promoter-enhancer associated with markedly less viral RNA production.</clue>
</event>
<event KT="Other" id="E102">
<type class="Negative_regulation"/>
<theme idref="E101"/>
<clue><clueLoc>In THP-1 cells</clueLoc> with <clueType>restricted</clueType> HIV expression, there is an absence of DNA-protein binding complex formation with the HIV-1 promoter-enhancer associated with markedly less viral RNA production.</clue>
</event>
<event KT="Other" id="E5">
<type class="Binding"/>
<theme idref="T14"/>
<theme idref="A12"/>
<clue>In THP-1 cells with restricted HIV expression, there is an absence of <corefTheme>DNA</corefTheme>-protein <clueType>binding complex formation</clueType> with the HIV-1 promoter-enhancer associated with markedly less viral RNA production.</clue>
</event>
<event LT="Propositional" id="E6">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<clue><clueLoc>In THP-1 cells with restricted HIV expression</clueLoc>, there is an <clueType>absence</clueType> <linkTheme>of</linkTheme> DNA-protein binding complex formation with the HIV-1 promoter-enhancer associated with markedly less viral RNA production.</clue>
</event>
<event id="E103">
<type class="Transcription"/>
<theme idref="T16"/>
<clue>In THP-1 cells with restricted HIV expression, there is an absence of DNA-protein binding complex formation with the HIV-1 promoter-enhancer associated with markedly less viral RNA <clueType>production</clueType>.</clue>
</event>
<event KT="Other" Manner="High" id="E104">
<type class="Negative_regulation"/>
<theme idref="E103"/>
<clue><clueLoc>In THP-1 cells with restricted HIV expression</clueLoc>, there is an absence of DNA-protein binding complex formation with the HIV-1 promoter-enhancer associated with <clueManner>markedly</clueManner> <clueType>less</clueType> viral RNA production.</clue>
</event>
<event LT="Propositional" id="E105">
<type class="Correlation"/>
<theme idref="E104"/>
<theme idref="E6"/>
<clue>In THP-1 cells with restricted HIV expression, there is an absence of DNA-protein binding complex formation with the HIV-1 promoter-enhancer <clueType>associated</clueType> <linkTheme>with</linkTheme> markedly less viral RNA production.</clue>
</event>
<sentence id="S5">This absence of binding was localized to the <term id="T17" lex="NF-kappa_B_region" sem="DNA_domain_or_region"><term id="T18" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> region</term> of the <term id="T19" lex="HIV-1_enhancer" sem="DNA_domain_or_region"><term id="T20" lex="HIV-1" sem="Virus">HIV-1</term> enhancer</term>; the <term id="T21" lex="65-kDa_plus_50-kDa_NF-kappa_B_heterodimer" sem="Protein_complex"><term id="A4" sem="Protein_molecule">65-kDa</term> plus <term id="A5" sem="Protein_molecule">50-kDa</term> <term id="T22" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> heterodimer</term> was preferentially lost.</sentence>
<event id="E11">
<type class="Binding"/>
<theme idref="A4"/>
<theme idref="A5"/>
<clue>This absence of binding was localized to the NF-kappa B region of the HIV-1 enhancer; the 65-kDa <linkTheme>plus</linkTheme> 50-kDa NF-kappa B <clueType>heterodimer</clueType> was preferentially lost.</clue>
</event>
<event LT="Propositional" id="E106">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<clue>This absence of binding was localized to the NF-kappa B region of the HIV-1 enhancer; the 65-kDa plus 50-kDa NF-kappa B heterodimer was preferentially <clueType>lost</clueType>.</clue>
</event>
<sentence id="S6">Adding purified <term id="T23" lex="NF-kappa_B_protein" sem="Protein_molecule"><term id="T24" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> protein</term> to <term id="T25" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term> from cells with <term id="T26" lex="restricted_expression" sem="Other">restricted expression</term> overcomes this lack of binding.</sentence>
<event LT="Propositional" id="E9">
<type class="Negative_regulation"/>
<theme idref="E106"/>
<cause idref="T23"/>
<clue>Adding purified NF-kappa B protein to <clueLoc>nuclear extracts from cells with restricted expression</clueLoc> <clueType>overcomes</clueType> <corefTheme>this lack of binding</corefTheme>.</clue>
</event>
<sentence id="S7">In addition, treatment of these <term id="T27" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term> with <term id="T28" lex="sodium_deoxycholate" sem="Organic_compound_other">sodium deoxycholate</term> restored their ability to form the <term id="T29" lex="heterodimer" sem="Protein_complex">heterodimer</term>, suggesting the presence of an inhibitor of <term id="T30" lex="NF-kappa_B_activity" sem="Other"><term id="T31" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activity</term>.</sentence>
<event KT="Method" id="E107">
<type class="Artificial_process"/>
<theme idref="T27"/>
<theme idref="T28"/>
<clue>In addition, <clueType>treatment</clueType> <linkTheme>of</linkTheme> these nuclear extracts <linkTheme>with</linkTheme> sodium deoxycholate restored their ability to form the heterodimer, suggesting the presence of an inhibitor of NF-kappa B activity.</clue>
</event>
<event LT="Propositional" id="E10">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="E107"/>
<clue>In addition, treatment of <clueLoc>these nuclear extracts</clueLoc> with sodium deoxycholate <clueType>restored</clueType> their ability to <linkTheme>form the heterodimer</linkTheme>, suggesting the presence of an inhibitor of NF-kappa B activity.</clue>
</event>
<sentence id="S8">Furthermore, treatment of <term id="A100" sem="Cell_component"><term id="T32" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term> from these cells that had <term id="T33" lex="restricted_expression" sem="Other">restricted expression</term></term> with <term id="T34" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> increased <term id="A6" sem="Virus">viral</term> production and <term id="T35" lex="NF-kappa_B_activity" sem="Other"><term id="T36" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activity</term>.</sentence>
<event id="E12">
<type class="Viral_life_cycle"/>
<theme idref="A6"/>
<clue>Furthermore, treatment of nuclear extracts from these cells that had restricted expression with lipopolysaccharide increased viral <clueType>production</clueType> and NF-kappa B activity.</clue>
</event>
<event KT="Method" id="E108">
<type class="Artificial_process"/>
<theme idref="A100"/>
<theme idref="T34"/>
<clue>Furthermore, <clueType>treatment</clueType> <linkTheme>of</linkTheme> nuclear extracts from these cells that had restricted expression <linkTheme>with</linkTheme> lipopolysaccharide increased viral production and NF-kappa B activity.</clue>
<comment>TPS: A100</comment></event>
<event LT="Propositional" id="E13">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="E108"/>
<clue>Furthermore, treatment of nuclear extracts from these cells that had restricted expression with lipopolysaccharide <clueType>increased</clueType> viral production and NF-kappa B activity.</clue>
</event>
<event LT="Propositional" id="E14">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<cause idref="E108"/>
<clue>Furthermore, treatment of nuclear extracts from these cells that had restricted expression with lipopolysaccharide <clueType>increased</clueType> viral production and NF-kappa B activity.</clue>
</event>
<sentence id="S9"><term id="A7" sem="Protein_family_or_group">Antiserum specific for <term id="T37" lex="NF-kappa_B_binding_protein" sem="Protein_family_or_group"><term id="T38" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> binding proteins</term></term>, but not <term id="T39" lex="c-rel-specific_antiserum" sem="Organic_compound_other">c-rel-specific antiserum</term>, disrupted <term id="T40" lex="heterodimer_complex_formation" sem="Other"><term id="T41" lex="heterodimer_complex" sem="Protein_complex">heterodimer complex</term> formation</term>.</sentence>
<event LT="Propositional" id="E15">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="A7"/>
<clue>Antiserum specific for NF-kappa B binding proteins, but not c-rel-specific antiserum, <clueType>disrupted</clueType> <linkTheme>heterodimer complex formation</linkTheme>.</clue>
<comment>TPS: A7</comment></event>
<event LT="Propositional" Polarity="Negative" assertion="non-exist" id="E16">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="T39"/>
<clue>Antiserum specific for NF-kappa B binding proteins, but <cluePolarity>not</cluePolarity> c-rel-specific antiserum, <clueType>disrupted</clueType> <linkTheme>heterodimer complex formation</linkTheme>.</clue>
</event>
<sentence id="S10">Thus, both <term id="T42" lex="NF-kappa_B-binding_complex" sem="Protein_complex"><term id="T43" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>-binding complexes</term> are needed for <term id="T44" lex="optimal_viral_transcription" sem="Other">optimal <term id="A8" sem="Virus">viral</term> transcription</term>.</sentence>
<event KT="Other" id="E17">
<type class="Transcription"/>
<theme idref="A8"/>
<clue>Thus, both NF-kappa B-binding complexes are needed for optimal viral <clueType>transcription</clueType>.</clue>
</event>
<event KT="Analysis" LT="Propositional" id="E18">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="T42"/>
<clue><clueKT>Thus</clueKT>, both NF-kappa B-binding complexes are <clueType>needed</clueType> <linkTheme>for</linkTheme> optimal viral transcription.</clue>
</event>
<sentence id="S11">Binding of the <term id="T45" lex="65-kDa" sem="Protein_molecule">65-kDa</term> plus <term id="T46" lex="50-kDa_heterodimer" sem="Protein_complex"><term id="A9" sem="Protein_molecule">50-kDa</term> heterodimer</term> to the <term id="T47" lex="HIV-1_enhancer" sem="DNA_domain_or_region"><term id="T48" lex="HIV-1" sem="Virus">HIV-1</term> enhancer</term> can be negatively regulated in <term id="T49" lex="monocyte" sem="Cell_natural">monocytes</term>, providing one <term id="A10" sem="Other">mechanism</term> restricting <term id="T50" lex="HIV-1_gene_expressionp" sem="Other"><term id="T51" lex="HIV-1_gene" sem="DNA_domain_or_region"><term id="T52" lex="HIV-1" sem="Virus">HIV-1</term> gene</term> expression</term>.</sentence>
<event KT="Other" id="E19">
<type class="Binding"/>
<theme idref="T45"/>
<theme idref="A9"/>
<clue>Binding of the 65-kDa <linkTheme>plus</linkTheme> 50-kDa <clueType>heterodimer</clueType> to the HIV-1 enhancer can be negatively regulated in monocytes, providing one mechanism restricting HIV-1 gene expression.</clue>
</event>
<event KT="Other" id="E20">
<type class="Binding"/>
<theme idref="T45" idref1="T46"/>
<theme idref="T47"/>
<clue><clueType>Binding</clueType> <linkTheme>of</linkTheme> the 65-kDa plus 50-kDa heterodimer <linkTheme>to</linkTheme> the HIV-1 enhancer can be negatively regulated in monocytes, providing one mechanism restricting HIV-1 gene expression.</clue>
</event>
<event KT="Other" id="E21">
<type class="Gene_expression"/>
<theme idref="T52"/>
<clue>Binding of the 65-kDa plus 50-kDa heterodimer to the HIV-1 enhancer can be negatively regulated in monocytes, providing one mechanism restricting HIV-1 gene <clueType>expression</clueType>.</clue>
</event>
<event CL="L2" KT="Analysis" LT="Propositional" id="E22">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="E23"/>
<clue>Binding of the 65-kDa plus 50-kDa heterodimer to the HIV-1 enhancer <clueKT><clueCL>can</clueCL></clueKT> be negatively regulated in monocytes, providing one mechanism <clueType>restricting</clueType> HIV-1 gene expression.</clue>
</event>
<event CL="L2" KT="Analysis" LT="Propositional" id="E23">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<clue>Binding of the 65-kDa plus 50-kDa heterodimer to the HIV-1 enhancer <clueKT><clueCL>can</clueCL></clueKT> be <clueType>negatively regulated</clueType> <clueLoc>in monocytes</clueLoc>, providing one mechanism restricting HIV-1 gene expression.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
